Weight loss drugs like Ozempic may help prevent stroke and reduce brain injury-related complications, studies show
Three studies presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impact of stroke and related brain injuries or reduce the risk of stroke altogether. These medications, which lower blood sugar and often cause weight loss, are commonly prescribed for type 2 diabetes and obesity and include drugs like semaglutide (Ozempic).
Should We Be Concerned About Glucagon-Like Peptide-1 Receptor Agonists?
In this issue of JAMA Ophthalmology, Shor and colleagues highlight a new potential concern for individuals taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They conducted a cohort study using an administrative health database that encompasses all of Ontario, Canada, to examine the risk of progression to new neovascular age-related macular degeneration (nAMD) among patients with […]
GLP-1 Drugs Linked to GERD; Best Upfront Approach for H. Pylori? AI in Colonoscopy
(MedPage Today) — In patients with type 2 diabetes, GLP-1 receptor agonists were associated with a higher risk for gastroesophageal reflux disease (GERD) compared with SGLT-2 inhibitors. (Annals of Internal Medicine) A similar study in Gastro…
Targeted in vivo gene integration of a secretion-enabled GLP-1 receptor agonist reverses diet-induced non-genetic obesity and pre-diabetes
submitted by /u/ahothabeth [link] [comments]
‘Exploding’ pills could deliver insulin without a needle
Researchers have created a pill that could effectively deliver insulin and other injectable drugs, making medicines for chronic illnesses easier for patients to take, less invasive, and potentially less expensive. Along with insulin, it also could be used for semaglutide—the popular GLP-1 medication sold as Ozempic and Wegovy—and a host of other top-selling protein-based medications […]
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
THURSDAY, July 17, 2025 — Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is independently associated with less improvement in glucose homeostasis, according…